Ingredient
Butylphenyl Methylpropional
Butylphenyl Methylpropional is flagged for pregnancy, breastfeeding, postpartum, trying to conceive, PCOS and general use. The concern behind the strongest flag is known teratogen and hormone disruptor.
- Lilial
- BMHCA
- P-MBMPCA
- Methlyproprional
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Not Recommended
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 6 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 2 of 5
- Higher means more likely to sting or redden
Butylphenyl Methylpropional and pregnancy
Not Recommended
- Known teratogen
- Hormone disruptor
- Fetal development
Butylphenyl methylpropional, also known as Lilial, is a synthetic fragrance compound that was commonly used to provide a lily-of-the-valley scent in cosmetics and personal care products. It functions solely as a perfuming agent and has no beneficial skincare properties. The European Commission's Scientific Committee on Consumer Safety (SCCS) concluded that this ingredient is a reproductive toxicant based on animal studies showing adverse effects on fertility and fetal development. These studies demonstrated that exposure could affect reproductive organs and potentially cause developmental abnormalities. Due to these concerns, the SCCS stated that butylphenyl methylpropional cannot be considered safe for use in cosmetic products, particularly for women of reproductive age. The EU banned this ingredient from all cosmetics effective March 2022, specifically citing reproductive toxicity concerns. Pregnant women should avoid any products containing this ingredient, though it should no longer appear in products manufactured for the EU market. Products manufactured before the ban or for markets outside the EU may still contain it. Check ingredient lists carefully and avoid products listing butylphenyl methylpropional, Lilial, BMHCA, or P-MBMPCA.
Butylphenyl Methylpropional and breastfeeding
Not Recommended
- Hormone disruptor
- Infant exposure
Butylphenyl methylpropional should be avoided during breastfeeding due to the same reproductive toxicity concerns identified by the SCCS. While specific studies on transfer to breast milk are limited, the ingredient's potential for endocrine disruption and effects on reproductive tissues make it inadvisable for breastfeeding mothers. The European ban on this ingredient applies to all cosmetic products regardless of the user's reproductive status, reflecting the serious nature of the safety concerns. Even topical exposure should be avoided as fragrances can be absorbed through the skin and the potential impact on a breastfed infant cannot be ruled out. Given that this ingredient provides only a fragrance benefit with no therapeutic value, the risk-benefit analysis clearly favors avoiding it during breastfeeding. Choose fragrance-free products or those scented with alternative fragrance compounds that have better safety profiles.
Butylphenyl Methylpropional and postpartum
Not Recommended
- Hormone disruptor
Even for postpartum women who are not breastfeeding, butylphenyl methylpropional should be avoided. The reproductive toxicity concerns identified by the SCCS apply to all women of reproductive age, as the ingredient may affect future fertility and reproductive health. The EU's decision to ban this ingredient was based on its potential to harm reproductive function, not just during active pregnancy or breastfeeding. For women who may become pregnant again in the future, continued exposure to reproductive toxicants is not advisable. Since this ingredient serves only a cosmetic purpose (fragrance) with no skincare benefits, there is no reason to accept the associated risks.
Butylphenyl Methylpropional and trying to conceive
Not Recommended
- Fertility effects
- Hormone disruptor
Women trying to conceive should absolutely avoid butylphenyl methylpropional. The EU ban was specifically motivated by reproductive toxicity concerns, including potential effects on fertility. Animal studies showed adverse effects on reproductive organs and reproductive function, which are directly relevant to women attempting to conceive. The SCCS evaluation noted that the ingredient could not be considered safe for use by consumers, with particular concern for women of reproductive potential. When trying to conceive, minimizing exposure to reproductive toxicants is a key principle of preconception care. Since this ingredient offers no health benefits and serves only as a fragrance, it should be eliminated from your personal care routine while trying to conceive and throughout any subsequent pregnancy.
Butylphenyl Methylpropional and PCOS
Not Recommended
- Interferes with hormones
- Endocrine disruptor
Women with PCOS should avoid butylphenyl methylpropional due to its classification as a potential endocrine disruptor. PCOS is fundamentally a hormonal disorder, and exposure to compounds that may interfere with hormone function could potentially worsen hormonal imbalances. The SCCS's concerns about reproductive toxicity include potential endocrine-disrupting effects. For women with PCOS who already experience hormonal dysregulation, adding a synthetic compound with hormone-disrupting potential is particularly inadvisable. While the direct effects on PCOS symptoms haven't been specifically studied, the precautionary principle strongly suggests avoidance. Given the EU ban and the availability of many alternative fragrance ingredients, there is no compelling reason for anyone, especially those with hormonal conditions like PCOS, to use products containing this ingredient. Choose products that are either fragrance-free or use alternative fragrance compounds.
Butylphenyl Methylpropional and general use
Not Recommended
- Common allergen
- Endocrine disruptor
Butylphenyl methylpropional (Lilial) was once a widely used fragrance ingredient, but scientific evidence of its risks led to a complete ban in the European Union effective March 2022. The European Commission's Scientific Committee on Consumer Safety conducted a thorough review and concluded that this ingredient poses unacceptable risks to human health. The SCCS identified two main concerns: reproductive toxicity and skin sensitization. Animal studies showed that exposure affected reproductive organs and fertility, and could cause developmental problems in offspring. Additionally, the ingredient is a known skin sensitizer that can cause allergic contact dermatitis, particularly with repeated exposure. The committee determined that no safe concentration could be established for use in cosmetics. Following the EU ban, many international brands reformulated their products to remove this ingredient globally, not just for EU markets. However, products manufactured before the ban or in regions without restrictions may still contain it. Consumers should check ingredient lists and avoid products containing butylphenyl methylpropional, Lilial, BMHCA, or P-MBMPCA. Numerous safer fragrance alternatives exist, and many products are now formulated fragrance-free.
Everything else flagged for the same profiles
Related ingredients
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store